Clinical Trial Update: Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating susceptibility-guided bismuth quadruple therapy for multiple-drug-resistant Helicobacter pylori has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)
• METRONIDAZOLE (Metronidazole)
• Omeprazole (Omeprazole)
• tetracycline (tetracycline)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Helicobacter Pylori, Drug Resistance, Multiple | Phase 4 | Status: COMPLETED